Bellevue Group AG raised its stake in shares of MacroGenics, Inc. (NASDAQ:MGNX – Free Report) by 1.5% in the fourth quarter, Holdings Channel.com reports. The firm owned 9,953,313 shares of the biopharmaceutical company’s stock after buying an additional 150,000 shares during the period. MacroGenics comprises approximately 1.5% of Bellevue Group AG’s investment portfolio, making the […]
Bellevue Group AG boosted its position in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 7.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,091,000 shares of the company’s stock after purchasing an additional 369,500 shares during the period. Revolution Medicines […]
Bellevue Group AG increased its stake in Silk Road Medical, Inc (NASDAQ:SILK – Free Report) by 0.4% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,435,682 shares of the company’s stock after buying an additional 5,120 shares during the quarter. Bellevue Group AG […]
Bellevue Group AG increased its stake in Silk Road Medical, Inc (NASDAQ:SILK – Free Report) by 0.4% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,435,682 shares of the company’s stock after buying an additional 5,120 shares during the quarter. Bellevue Group AG […]
Bellevue Group AG grew its holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Free Report) by 4.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 8,535,839 shares of the company’s stock after buying an additional 400,000 shares during the quarter. Bellevue […]